Article Text
Abstract
The use of human tissue for scientific research is a highly sensitive issue. A lack of confidence in patient recruitment is one reason for the failure of many studies to be funded and it is important therefore that recruitment procedures are as effective and sympathetic as possible. The authors recruited patients with uveal melanoma into a postmortem study investigating tumour latency in this cancer. Two approaches were used—firstly a direct approach when patients attended clinic and secondly an initial approach by mail followed by telephone contact. In the first year of study the authors had a take up rate of 88.5%, significantly higher than the average rate of 40% quoted by the National Institute for Clinical Excellence (NICE). Key features are a sympathetic personal approach by experienced oncology nurses, the provision of clear information, and the inclusion of the next of kin in the recruitment procedure.
- uveal melanoma
- postmortem
- tissue donors
- recruitment
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma
- Uveal melanoma-associated cancers revisited
- Methylation of CpG island promoters in uveal melanoma
- Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
- Metastatic disease from uveal melanoma: treatment options and future prospects
- CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation
- The Zimmerman-McLean-Foster hypothesis: 25 years later
- The relation between c-myc expression and interferon sensitivity in uveal melanoma
- Chromosomal aberrations in iris melanomas
- Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients